https://edenbiologics.com/wp-content/uploads/2024/04/eden-logo.png
219
481
admin
http://edenbiologics.com/wp-content/uploads/2024/04/eden-logo-s.png
admin2022-07-06 09:00:002024-04-17 09:30:43Eden Biologics, Inc. Announces the Completion of the Sale of CDMO Business Assets
https://edenbiologics.com/wp-content/uploads/2024/04/eden-logo.png
219
481
admin
http://edenbiologics.com/wp-content/uploads/2024/04/eden-logo-s.png
admin2021-09-21 09:00:002024-04-17 08:51:14Eden Biologics Introduces New Chief Executive Officer, Dr. Steve Lee
https://edenbiologics.com/wp-content/uploads/2024/04/eden-logo.png
219
481
admin
http://edenbiologics.com/wp-content/uploads/2024/04/eden-logo-s.png
admin2021-08-31 09:00:002024-04-17 08:50:37Eden Biologics’ Leading Biosimilar Program Receives Phase 3 Approval in Europe
https://edenbiologics.com/wp-content/uploads/2024/04/eden-logo.png
219
481
admin
http://edenbiologics.com/wp-content/uploads/2024/04/eden-logo-s.png
admin2021-07-09 09:00:002024-04-17 08:50:18Eden Biologics Statement
https://edenbiologics.com/wp-content/uploads/2021/03/Scott-Liu_s.png
219
481
admin
http://edenbiologics.com/wp-content/uploads/2024/04/eden-logo-s.png
admin2021-03-15 09:00:002024-04-17 09:15:28Eden Biologics Proudly Announces Dr. Scott Liu as Board Member
https://edenbiologics.com/wp-content/uploads/2024/04/eden-logo.png
219
481
admin
http://edenbiologics.com/wp-content/uploads/2024/04/eden-logo-s.png
admin2021-02-25 09:00:002024-04-17 09:16:11Eden Biologics Anticipates Initiation of Global Phase 3 in 2021 H2 for Its Denosumab Biosimilar
https://edenbiologics.com/wp-content/uploads/2024/04/eden-logo.png
219
481
admin
http://edenbiologics.com/wp-content/uploads/2024/04/eden-logo-s.png
admin2021-02-19 09:51:002024-04-17 08:49:29JHL Biotech Officially Changes Name to EDEN Biologics
https://edenbiologics.com/wp-content/uploads/2020/05/QSera-logo_s.png
219
481
admin
http://edenbiologics.com/wp-content/uploads/2024/04/eden-logo-s.png
admin2020-05-22 09:00:002024-04-17 09:11:12Q-Sera Pty Ltd and JHL Biotech, Inc. Announce a Strategic Collaboration
https://edenbiologics.com/wp-content/uploads/2024/04/eden-logo.png
219
481
admin
http://edenbiologics.com/wp-content/uploads/2024/04/eden-logo-s.png
admin2020-05-18 09:00:002024-04-17 08:48:49First Subjects Dosed in Australian Phase I Clinical Study of a Denosumab Biosimilar
